Based on the recent data, PCAR stock shows mixed signals that suggest caution. Recent insider selling activity with the CFO disposing of 20% of holdings and no insider purchases in the past 6 months indicates potential concerns from company leadership. Additionally, institutional investors show divided sentiment with 459 increasing and 529 decreasing their positions.
The stock has significantly underperformed the broader market, gaining only 3.3% compared to the S&P 500's 22.8% rise over the past year. Q4 earnings missed estimates with adjusted EPS of $1.66, down 38.5% year-over-year, while revenue declined 14.3% to $7.4 billion.
However, there are some positive indicators:
- JPMorgan recently raised its price target to $132, suggesting 22.6% upside potential
- Consensus rating remains "Moderate Buy" from 15 analysts
- Peter Lynch's P/E/Growth model gives PCAR a strong 91% rating
Given the recent insider selling, weak earnings performance, and significant market underperformance, selling PCAR stock appears to be the more prudent action at current levels despite some positive analyst sentiment.